store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Muramyl dipeptide (MDP) 是合成的免疫反应肽,由 N-乙酰壁酸与 L-Ala-D-isoGln 的短氨基酸链相连。它通过MAPK 途径上调 Runx2 基因表达,直接促进成骨细胞分化,通过降低 RANKL/OPG 比值间接抑制破骨细胞分化。它是通过Runx2诱导骨形成的诱导因子,也是NLRP1激动剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 1,110 | 现货 | ||
5 mg | ¥ 1,990 | 现货 | ||
10 mg | ¥ 2,970 | 现货 | ||
25 mg | ¥ 5,270 | 现货 | ||
50 mg | ¥ 7,430 | 现货 | ||
100 mg | ¥ 9,820 | 现货 | ||
500 mg | ¥ 19,600 | 5日内发货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,160 | 现货 |
产品描述 | Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide indirectly decreases osteoclast differentiation through a decreased RANKL/OPG ratio. Muramyl dipeptide directly increases osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is an inducer of bone formation through the induction of Runx2 . |
体外活性 | Muramyl dipeptide increases the protein expression of Runx2 in a dose-dependent manner (0.1-10 μg/mL; 24 hours)[1]. It also enhances the mRNA levels of Runx2 in a dose-dependent manner (0.1-10 μg/mL; 6 hours)[2]. Muramyl dipeptide indirectly attenuates osteoclast differentiation by reducing the RANKL/OPG ratio[2]. |
体内活性 |
Muramyl dipeptide can be used for animal modeling to establish sepsis models. Muramyl dipeptide (1.25 mg/kg; intraperitoneal injection; twice) alleviates osteoporosis-induced bone loss[2]. |
别名 | MDP |
分子量 | 492.48 |
分子式 | C19H32N4O11 |
CAS No. | 53678-77-6 |
store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (101.53 mM), Sonification is recommended.
H2O: 20 mg/mL (40.61 mM), Sonification is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 2.0305 mL | 10.1527 mL | 20.3054 mL | 50.7635 mL |
5 mM | 0.4061 mL | 2.0305 mL | 4.0611 mL | 10.1527 mL | |
10 mM | 0.2031 mL | 1.0153 mL | 2.0305 mL | 5.0763 mL | |
20 mM | 0.1015 mL | 0.5076 mL | 1.0153 mL | 2.5382 mL | |
DMSO | 50 mM | 0.0406 mL | 0.2031 mL | 0.4061 mL | 1.0153 mL |
100 mM | 0.0203 mL | 0.1015 mL | 0.2031 mL | 0.5076 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Muramyl dipeptide 53678-77-6 Immunology/Inflammation NF-Κb NOD MDP Inhibitor inhibitor inhibit